Saznaj više

• Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
• Best Practices in Fragile X Syndrome Treatment Development
• Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment
• The fragile X syndrome-autism comorbidity: what do we really know?
• Q&A With Dr. Hagerman: Exploring the Fragile X Syndrome / Autism Link
• FXCRC Consensus Document: Autism Spectrum Disorder in Fragile X Syndrom
• The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
• Fragile X-Associated Neuropsychiatric Disorders (FXAND)
• New Targeted Treatments for Fragile X Syndrome
• Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals
• Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
• Fragile X targeted pharmacotherapy: lessons learned and future directions
• Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin–two cases
• FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia
• New Finding on Early Detection and Early Intervention in Autism Spectrum Disorder — Information and Resources for Parents and Providers
• Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
• Fragile X syndrome: leading the way as the most common monogenic form of autism spectrum disorder and the most translated among neurodevelopmental disorders in clinical trials
• Fragile X Gene Premutation: To Recognize Early and Treat Neuropsychiatric Problems